CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


ResveratrolWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug2854 impliminting Online Distance Learning Wiki 1.00
drug2664 Vitamin D3 Wiki 0.50

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Randomized Double-Blind Placebo-Controlled Proof-of-Concept Trial of Resveratrol for the Outpatient Treatment of Mild Coronavirus Disease (COVID-19)

There is evidence that resveratrol might help fight coronavirus as well as help protect the body from the effects of disease (COVID-19) caused by the infection. In this proof-of-concept pilot study we will compare the effects of resveratrol to placebo to assess the safety of resveratrol and explore effectiveness.

NCT04400890 COVID-19 Drug: Resveratrol Dietary Supplement: Vitamin D3

Primary Outcomes

Description: Proportion of study participants admitted to the hospital within 21 days of testing positive

Measure: Hospitalization rates for COVID-19

Time: 21 days from testing positive from COVID-19

Secondary Outcomes

Description: Proportion of study participants admitted to the ICU within 21 days of testing positive

Measure: ICU Admission Rates

Time: 21 days from testing positive from COVID-19

Description: Proportion of study participants receiving invasive ventilation within 21 days of testing positive

Measure: Invasive Ventilation Rates

Time: 21 days from testing positive from COVID-19

Other Outcomes

Description: Modified BORG scale, visual analog scale for fatigue

Measure: Reported symptom severity

Time: 21 days from testing positive from COVID-19

Description: Diarrhea, nausea, abdominal cramping

Measure: Adverse events

Time: 21 days from testing positive from COVID-19


No related HPO nodes (Using clinical trials)